November 21, 2018
Transplant remains the standard of care for eligible patients with newly diagnosed multiple myeloma, although the optimal induction regimen and value of consolidation is still debated, explained Ravi Vij, MD. However, in patients who are ineligible for transplant, Vij noted that proteasome inhibitors and monoclonal antibodies are showing promise in the frontline setting and may...
Continue Reading

Floor 7, 90 The Terrace
Wellington Central
New Zealand